FISHER & PAYKEL HEAL

FPH
End-of-day quote. End-of-day quote  - 11/26
32.59NZD -2.86%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2020 2021
Net sales1 1 2641 796
EBITDA1 430673
Operating profit (EBIT)1 379603
Operating Margin 30,0%33,6%
Pre-Tax Profit (EBT)1 371609
Net income1 287446
Net margin 22,7%24,8%
EPS2 0,500,78
Dividend per Share2 0,280,40
Last update 06/28/202011/25/2020
1 NZD in Million
2 NZD
Estimates
Finances - Leverage
Fiscal Period: March 2020 2021
Net Debt1 --
Net Cash position1 42,289,4
Leverage (Debt / EBITDA) -0,10x-0,13x
Free Cash Flow1 151277
ROE (Net Profit / Equities) 30,5%38,8%
Shareholders' equity1 9441 149
ROA (Net Profit / Asset) 21,8%28,0%
Assets1 1 3211 593
Book Value Per Share2 1,682,16
Cash Flow per Share2 0,560,79
Capex1 171178
Capex / Sales 13,5%9,93%
Last update 06/28/202011/25/2020
1 NZD in Million
2 NZD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 18 714 M NZD -
Entreprise Value (EV) 18 624 M NZD 18 494 M NZD
Valuation 2021e 2022e
P/E ratio (Price / EPS) 42,0x 47,4x
Capitalization / Revenue 10,4x 11,1x
EV / Revenue 10,4x 11,1x
EV / EBITDA 27,7x 30,8x
Yield (DPS / Price) 1,24% 1,35%
Price to book (Price / BVPS) 15,1x 13,6x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 33,6% 31,5%
Operating Leverage (Delta EBIT / Delta Sales) 1,40x -1,91x
Net Margin (Net Profit / Revenue) 24,8% 23,7%
ROA (Net Profit / Asset) 28,0% 25,8%
ROE (Net Profit / Equities) 38,8% 29,8%
Rate of Dividend 52,0% 63,7%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   9,93% 7,27%
Cash Flow / Sales 25,4% 28,8%
Capital Intensity (Assets / Sales) 0,89x 0,92x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend